One of the priority and unresolved tasks in practical healthcare is the problem of prevention and treatment of inflammatory diseases of the maxillofacial area. Inflammatory diseases of the maxillofacial area can be the result not only of complications of the carious process, but of planned surgical operations without signs of septic inflammation in the early postoperative period. A dentist-surgeon prescribes antibacterial therapy for the purpose of prophylaxis to minimize the risk of developing purulent-inflammatory complications in the postoperative period, which increases the probability of the success of the performed surgery and makes the treatment more effective. Tablet dosage forms of antibacterial drugs have a number of disadvantages. The desire of pharmacists to make medicines more accessible for different categories of patients, and the effect of the drug more effective and safe led to the creation of dispersible tablets. Modern dosage forms of dispersible tablets have high bioavailability, fewer adverse reactions, and demonstrate higher patient adherence to treatment, increasing the effectiveness of therapy and reducing the risk of antibiotic resistance.